XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.1
INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Marketable Securities
Gains recognized in other income, net on marketable equity securities were as follows:
In millionsQ1 2025Q1 2024
Net gains recognized during the period
$31 $
Less: Net gains recognized during the period on securities sold during the period
 — 
Net unrealized gains recognized during the period on securities still held at the reporting date$31 $
Schedule of Other Commitments
Our commitments to the Funds are as follows:
Dollars in millions
Capital commitments
Callable through date
Remaining callable as of March 30, 2025 (1)
Fund I
$100 April 2026$
Fund II
$150 July 2029$42 
Fund III
$60 December 2034$47 
_____________
(1)Fund I also had recallable distributions of approximately $10 million.
Schedule of Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the hierarchy for assets and liabilities measured at fair value on a recurring basis:
March 30, 2025December 29, 2024
In millionsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Money market funds (cash equivalents)$927 $ $ $927 $931 $— $— $931 
Marketable equity securities124   124 93 — — 93 
Other investments
  17 17 — — 17 17 
Deferred compensation plan assets 70  70 — 70 — 70 
Total assets measured at fair value$1,051 $70 $17 $1,138 $1,024 $70 $17 $1,111 
Liabilities:
Contingent consideration liabilities$ $ $62 $62 $— $— $73 $73 
Deferred compensation plan liability 66  66 — 65 — 65 
Total liabilities measured at fair value$ $66 $62 $128 $— $65 $73 $138 
Schedule of Changes in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities
Changes in the estimated fair value of our contingent consideration liabilities during Q1 2025 were as follows:
In millions
Balance as of December 29, 2024$73 
Change in estimated fair value(11)
Balance as of March 30, 2025$62